Relationships Among Physical Activity, Sleep, and Cancer-related Fatigue: Results From the International ColoCare Study
- PMID: 38141201
- PMCID: PMC10858307
- DOI: 10.1093/abm/kaad068
Relationships Among Physical Activity, Sleep, and Cancer-related Fatigue: Results From the International ColoCare Study
Abstract
Background: Risk factors for cancer-related fatigue are understudied in colorectal cancer.
Purpose: This study aimed to address this critical gap in the literature by (a) describing changes in colorectal cancer-related fatigue and health behavior (physical activity, sleep problems) and (b) examining if physical activity and sleep problems predict fatigue trajectories from baseline (approximately at the time of diagnosis), to 6- and 12 months after enrollment.
Methods: Patients participating in the international ColoCare Study completed self-report measures at baseline (approximately time of diagnosis), 6-, and 12 months assessing physical activity using the International Physical Activity Questionnaire (IPAQ) and fatigue and sleep using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30). Mixed-effect models examined changes in physical activity, sleep problems, and fatigue. Cross-lagged panel models examined bidirectional relationships between physical activity or sleep and fatigue across time.
Results: Colorectal cancer patients (n = 649) had a mean age of 61 ± 13 years. Most were male (59%), non-Hispanic White (91%), diagnosed with Stages III-IV (56%) colon cancer (58%), and treated with surgery (98%). Within-person cross-lagged models indicated higher physical activity at Month 6 was associated with higher fatigue at Month 12 (β = 0.26, p = .016). When stratified by cancer stage (I-II vs. III-IV), the relationship between physical activity at Month 6 and fatigue at Month 12 existed only for patients with advanced cancer (Stages III and IV, β = 0.43, p = .035). Cross-lagged associations for sleep and fatigue from baseline to Month 6 were only observed in patients with Stages III or IV cancer, however, there was a clear cross-sectional association between sleep problems and fatigue at baseline and Month 6.
Conclusions: Within-person and cross-lagged association models suggest fatiguability may become increasingly problematic for patients with advanced colorectal cancer the first year after diagnosis. In addition, sleep problems were consistently associated with higher fatigue in the first year, regardless of cancer stage.
Trial registration: The international ColoCare Study was registered on clinicaltrials.gov, NCT02328677, in December 2014.
Keywords: Colorectal cancer; Fatigue; Physical activity; Sleep; Survivors.
Plain language summary
Within-person and cross-lagged association models suggest fatiguability may become increasingly problematic for patients with advanced (Stages III and IV) colorectal cancer the first year after diagnosis.
© Society of Behavioral Medicine 2023. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures






References
-
- International Agency for Cancer Research. Colorectal cancer awareness month.2022. Available at https://www.iarc.who.int/featured-news/colorectal-cancer-awareness-month.... Accessibility verified February 15, 2023.
-
- Minton O, Stone P.. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol. 2009; 20(1):17–25. - PubMed
-
- Aapro M, Scotte F, Bouillet T, Currow D, Vigano A.. A practical approach to fatigue management in colorectal cancer. Clin Colorectal Cancer. 2017; 16(4):275–285. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- R03 CA270473/CA/NCI NIH HHS/United States
- R01 AG083580/AG/NIA NIH HHS/United States
- R01 CA189184/CA/NCI NIH HHS/United States
- U01 CA206110/CA/NCI NIH HHS/United States
- P30 CA076292/CA/NCI NIH HHS/United States
- R01 NR018762/NR/NINR NIH HHS/United States
- R01 CA254108/CA/NCI NIH HHS/United States
- U01 CA206110/NH/NIH HHS/United States
- R01NR018762/NR/NINR NIH HHS/United States
- R01 CA211705/CA/NCI NIH HHS/United States
- T32 HG008962/HG/NHGRI NIH HHS/United States
- T32CA009168/CA/NCI NIH HHS/United States
- KL2 TR002539/TR/NCATS NIH HHS/United States
- R01 CA207371/CA/NCI NIH HHS/United States
- K07 CA222060/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources